Status:
UNKNOWN
Progestin Treatment for Endometrial Stromal Cells in Adenomyosis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Endometriosis
Eligibility:
FEMALE
35-50 years
Brief Summary
Long term treatment of progestin has been demonstrated to have an inhibitory effect on endometrial angiogenesis and the proliferation of endometrial stromal cells. As a result, progestin is now widely...
Detailed Description
Eutopic endometrium was obtained and separated into single endometrial stromal cell (ESC) in women with adenomyosis (study group) and without adenomyosis (control group). After becoming pre-confluent...
Eligibility Criteria
Inclusion
- women with adenomyosis
- at early- to mid-secretory phases
Exclusion
- postmenopausal
- malignancy
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
End Date :
April 1 2005
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00155051
Start Date
July 1 2004
End Date
April 1 2005
Last Update
September 12 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100